Anguilla Tech Gazette
SEE OTHER BRANDS

Fresh news on science and technology in Anguilla

Anguilla Tech Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.

Press releases published on June 16, 2025

Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Inclusion reflects continued growth and momentum in the company’s mission to transform the treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) CHICAGO and FORT WORTH, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: …

Turtle Beach Corporation Amends Debt Agreement and Resumes Share Repurchases

Turtle Beach Corporation Amends Debt Agreement and Resumes Share Repurchases

SAN DIEGO, June 16, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH, the “Company”), a leading gaming accessories brand, today announced that it has secured a waiver under its existing debt agreement, allowing for share repurchases of up to …

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

OMER, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the receipt of an initial order for its …

Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

MORRISTOWN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTC:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B …

RIMining: Market Turmoil from War, Bitcoin Bounces to $106K, Free Cloud Mining App Becomes a Safe Asset Growth Choice

RIMining: Market Turmoil from War, Bitcoin Bounces to $106K, Free Cloud Mining App Becomes a Safe Asset Growth Choice

Seattle, Washington, June 16, 2025 (GLOBE NEWSWIRE) -- In 2025, escalating geopolitical tensions—most recently between Israel and Iran—have led to significant volatility in the cryptocurrency market. Bitcoin briefly dipped before bouncing back to $106,000, …

Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program

Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, June 16, 2025 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination immunotherapy platform for solid tumor cancers, today …

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for TEV- …

Empty Capsules Market Set for US$4.2B by 2029 — What Should Pharma and Nutraceutical Leaders Know?

Empty Capsules Market Set for US$4.2B by 2029 — What Should Pharma and Nutraceutical Leaders Know?

Delray Beach, FL, June 16, 2025 (GLOBE NEWSWIRE) -- The global empty capsules market is entering a pivotal phase—set to grow from US$3.1 billion in 2024 to US$4.2 billion by 2029, driven by evolving drug delivery technologies, booming nutraceutical demand, …

American Rebel Light Beer Expands into Virginia with Valley Distributing - Distribution Momentum Accelerates Nationwide

American Rebel Light Beer Expands into Virginia with Valley Distributing - Distribution Momentum Accelerates Nationwide

With a New Agreement for Southwestern Virginia and Active Distribution across 11 States Since Launching in September 2024, American Rebel Light Beer – America’s Patriotic Beer Continues its Rapid Rise as America’s Fastest Growing Beer NASHVILLE, TN,, June …

Aware Named Luminary in Prism Project Report as Organization Rolls Out New Platform Enhancements

Aware Named Luminary in Prism Project Report as Organization Rolls Out New Platform Enhancements

AMSTERDAM, June 16, 2025 (GLOBE NEWSWIRE) -- Identity Week Europe -- Aware, Inc. (NASDAQ: AWRE), a leader in global biometric authentication, was recognized as an industry Luminary in Core Identity Technology in the Prism Project’s Deepfake and Synthetic …

Astera Labs and Alchip Announce Strategic Partnership to Advance Silicon Ecosystem for AI Rack-Scale Connectivity

Astera Labs and Alchip Announce Strategic Partnership to Advance Silicon Ecosystem for AI Rack-Scale Connectivity

SANTA CLARA, Calif. and TAIPEI, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Astera Labs, a leading provider of purpose-built connectivity solutions for AI and cloud infrastructure, and Alchip Technologies, the high-performance ASIC leader, today announced a …

New mobile mining force: RichMiner’s 5 million users’ DOGE/BTC profit path

New mobile mining force: RichMiner’s 5 million users’ DOGE/BTC profit path

New York, NY, June 16, 2025 (GLOBE NEWSWIRE) -- With the continuous advancement of cloud mining and mobile terminal technology, more and more ordinary users no longer rely on high-cost hardware and can enter the crypto mining industry through mobile phones …

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health …

Shiplify and Trinity Logistics Honored with 2025 Top Supply Chain Project Award

Shiplify and Trinity Logistics Honored with 2025 Top Supply Chain Project Award

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, has been recognized by Supply …

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

SAN DIEGO, June 16, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host an in-person and virtual R…

Slide Raises $25M Series A led by Base10 Partners to Accelerate Market Growth, Expands to Canada

Slide Raises $25M Series A led by Base10 Partners to Accelerate Market Growth, Expands to Canada

NORWALK, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Slide, the next-generation BCDR (Business Continuity and Disaster Recovery) platform purpose-built for MSPs, today announced it has raised $25 million in Series A funding. The round was led by Base10 …

Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study

Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study

The Phase 2 Istaroxime study was successful in multiple endpoints showing promise for how it may be utilized if approved in its targeted indications    Primary endpoint of the study was met of increasing systolic blood pressure and demonstration of other …

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the U.S. …

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

LungFit PH II’s smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the country GARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- …

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

GLP-1/GIP receptor co-agonist designed to be highly potent and for once-monthly administration based on MBX’s novel PEP™ platform technology Phase 1 trial of MBX 4291 is expected to initiate in Q3 2025 CARMEL, Ind., June 16, 2025 (GLOBE NEWSWIRE) -- MBX …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service